Transcriptional attenuation in colon carcinoma cells in response to butyrate

Cancer Prevention Research

Volumn 3, Issue 10, 2010, Pages 1292-1302

  Daroqui, Maria C ^a   Augenlicht, Leonard H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLIN D1; HISTONE H3; MYC PROTEIN; RNA POLYMERASE II;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CHROMATIN; COLON CARCINOMA; ENZYME LOCALIZATION; GENE LOCUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METHYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; BLOTTING, WESTERN; BUTYRATES; CACO-2 CELLS; CELL LINE, TUMOR; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; CYCLIN D1; GENE EXPRESSION REGULATION; GENES, MYC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 77958573090     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0083     Document Type: Article

References (50)

1. Barnard JA, Warwick G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ 1993;4:495-501.
2. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993;55:498-505. (Pubitemid 23300605)
3. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 1994;54:3288-93.
4. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980;21:793-8.
5. Augenlicht LH, Anthony GM, Church TL, et al. Short-chain fatty acid metabolism, apoptosis, and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa. Cancer Res 1999;59:6005-9.
6. Heerdt BG, Augenlicht LH. Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. J Biol Chem 1991;266:19120-6.
7. Mariadason JM, Corner GA, Augenlicht LH. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 2000;60:4561-72.
8. Mariadason JM, Nicholas C, L'Italien KE, et al. Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 2005;128:1081-8. (Pubitemid 40523558)
9. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12. (Pubitemid 28425575)
10. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6. (Pubitemid 29180374)
11. Sancho E, Batlle E, Clevers H. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 2003;15:763-70. (Pubitemid 37487970)
12. Sansom OJ, Meniel VS, Muncan V, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007;446:676-9. (Pubitemid 46606884)
13. Hulit J, Wang C, Li Z, et al. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in Apc- Min mice. Mol Cell Biol 2004;24:7598-611. (Pubitemid 39121486)
14. Heruth DP, Zirnstein GW, Bradley JF, Rothberg PG. Sodium buty-rate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem 1993;268:20466-72.
15. Lallemand F, Courilleau D, Sabbah M, Redeuilh G, Mester J. Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem Biophys Res Commun 1996;229:163-9. (Pubitemid 27013725)
16. Bender TP, Thompson CB, Kuehl WM. Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science 1987;237:1473-6.
17. Chen Z, Harless ML, Wright DA, Kellems RE. Identification and characterization of transcriptional arrest sites in exon 1 of the human adenosine deaminase gene. Mol Cell Biol 1990;10:4555-64.
18. Mechti N, Piechaczyk M, Blanchard JM, Jeanteur P, Lebleu B. Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene. Mol Cell Biol 1991;11: 2832-41. (Pubitemid 21895665)
19. Middleton KM, Morgan GT. Premature termination of transcription can be induced on an injected α-tubulin gene in Xenopus oocytes. Mol Cell Biol 1990;10:727-35.
20. Tong X, Yin L, Joshi S, Rosenberg DW, Giardina C. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. J Biol Chem 2005;280: 15503-9.
21. Krumm A, Meulia T, Brunvand M, Groudine M. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev 1992;6:2201-13.
22. Raschke EE, Albert T, Eick D. Transcriptional regulation of the Igκ gene by promoter-proximal pausing of RNA polymerase II. J Immunol 1999;163:4375-82.
23. Wilson AJ, Velcich A, Arango D, et al. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res 2002;62:6006-10.
24. Zhang ZK, Davies KP, Allen J, et al. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol 2002;22: 5975-88.
25. Maier S, Daroqui MC, Scherer S, et al. Butyrate and vitamin D3 induce transcriptional attenuation at the cyclin D1 locus in colonic carcinoma cells. J Cell Physiol 2009;218:638-42.
26. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007;128:707-19.
27. Boffa LC, Vidali G, Mann RS, Allfrey VG. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 1978; 253:3364-6.
28. Turner BM. Histone acetylation and an epigenetic code. Bioessays 2000;22:836-45.
29. Mariadason JM, Rickard KL, Barkla DH, Augenlicht LH, Gibson PR. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J Cell Physiol 2000;183:347-54.
30. Daroqui MC, Puricelli LI, Urtreger AJ, Elizalde PV, Lanuza GM, Bal de Kier Joffe E. Involvement of TGF-β(s)/T(β)Rs system in tumor progression of murine mammary adenocarcinomas. Breast Cancer Res Treat 2003;80:287-301.
31. Sealy L, Chalkley R. The effect of sodium butyrate on histone modification. Cell 1978;14:115-21.
32. Barski A, Cuddapah S, Cui K, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-37.
33. Vakoc CR, Sachdeva MM, Wang H, Blobel GA. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol 2006;26:9185-95.
34. Carninci P, Sandelin A, Lenhard B, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet 2006; 38:626-35.
35. Price DH. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 2000;20:2629-34.
36. Tan S, Aso T, Conaway RC, Conaway JW. Roles for both the RAP30 and RAP74 subunits of transcription factor IIF in transcription initiation and elongation by RNA polymerase II. J Biol Chem 1994;269: 25684-91. (Pubitemid 24336264)
37. Kim YS, Milner JA. Dietary modulation of colon cancer risk. J Nutr 2007;137:2576-9S.
38. Bentley DL, Groudine M. Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 1988; 53:245-56.
39. Keene RG, Mueller A, Landick R, London L. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes. Nucleic Acids Res 1999;27:3173-82. (Pubitemid 29355733)
40. Wright S, Mirels LF, Calayag MC, Bishop JM. Premature termination of transcription from the P1 promoter of the mouse c-myc gene. Proc Natl Acad Sci U S A 1991;88:11383-7. (Pubitemid 21916045)
41. Ignatenko NA, Holubec H, Besselsen DG, et al. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer Biol Ther 2006;5:1658-64.
42. Bentley DL, Groudine M. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 1986;321:702-6. (Pubitemid 16044131)
43. Nepveu A, Marcu KB. Intragenic pausing and anti-sense transcription within the murine c-myc locus. EMBO J 1986;5:2859-65.
44. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002; 132:1012-7. (Pubitemid 34493567)
45. Rada-Iglesias A, Enroth S, Ameur A, et al. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res 2007;17: 708-19. (Pubitemid 46919708)
46. Bannister AJ, Schneider R, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T. Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes. J Biol Chem 2005;280:17732-6. (Pubitemid 41389011)
47. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 2007;130:77-88. (Pubitemid 47031323)
48. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007;447:407-12.
49. Saunders A, Core LJ, Lis JT. Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol 2006;7:557-67.
50. Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447:799-816. (Pubitemid 46920138)